Association of Haematological and Biochemical Inflammatory Indices with Angiographic Severity of Coronary Artery Disease in Chronic Stable Angina
摘要
Coronary artery disease (CAD) remains the leading cause of morbidity and mortality worldwide. The SYNTAX score is a validated angiographic tool for assessing CAD complexity. Haematological and biochemical inflammatory indices derived from routine complete blood counts (CBC), such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), monocyte-to-HDL ratio (MHR), and systemic immune-inflammation index (SII), may serve as simple and inexpensive predictors of CAD severity. This cross-sectional study included 491 patients with chronic stable angina undergoing coronary angiography, and lesions were analysed using SYNTAX score I. CBC-based indices (NLR, PLR, LMR, MHR, SII), lipid profile, triglyceride glucose (TyG) index, and hs-CRP were calculated. Correlation between these indices and SYNTAX score was analysed using Spearman’s correlation. The mean age of the study population was 60.4 ± 10.6 years, with hypertension (54.4%) and diabetes (42.0%) being the most prevalent comorbidities. The mean SYNTAX score was 16.5 ± 9.8. Among the haematological indices, NLR showed the strongest positive correlation with SYNTAX score (r = 0.428, p < 0.0001), followed by SII (r = 0.355, p < 0.0001) and hs-CRP (r = 0.322, p < 0.0001). PLR, MHR, LMR, and TyG index demonstrated weak or non-significant associations. Multivariable logistic regression analysis showed that elevated NLR (> 2.5) was significantly associated with high SYNTAX score (> 22). In conclusion, NLR demonstrated the strongest association with angiographic CAD severity, along with SII and hs-CRP, in this cross-sectional cohort. These indices are readily available and may complement clinical assessment and early risk stratification before invasive angiography; however, their predictive utility and routine clinical use require confirmation in prospective studies with multivariable modelling and outcome-based validation.